Abbreviations & Acronyms 24 h-U-Na = 24-h urinary sodium (Na) ANP = atrial natriuretic peptide BMI = body mass index BNP = brain natriuretic peptide CI = confidence interval CLSS = core lower urinary tract symptoms score H-salt = high salt group IPSS = International Prostate Symptom Score L-salt = low salt group LUTS = lower urinary tract symptoms NPi = nocturnal polyuria index OR = odds ratio QOL = quality of life r = correlation coefficient SD = standard deviation SUNa = sodium concentration in the spot voiding urine Objective: To clarify the relationships between daily salt intake and lower urinary tract symptoms. Methods: A cross-sectional clinical study was carried out with 728 patients. Spot urine samples were collected to evaluate estimated daily salt intake. The patients were divided into two groups based on mean salt intake (9.2 g/day). Their urinary condition was evaluated using the Core Lower Urinary Tract Symptoms score and 3-day frequency volume charts. The influence of salt intake on lower urinary tract symptoms was investigated using multivariate logistic regression analysis. Results: Daytime frequency (Q1) and nocturia (Q2) in the high salt intake group (H-salt group) were higher compared with those in the low salt intake group (L-salt group); P < 0.001). The quality of life scores and nocturnal polyuria index in the H-salt group were worse than those in the L-salt group (P < 0.001). Multivariate analyses showed daily salt intake is an independent worsening factor for high daytime frequency (odds ratio 2.32, 95% confidential interval 1.66-3.25, P < 0.001) and nocturia (odds ratio 3.05, 95% confidential interval 2.08-4.52, P < 0.001). Similarly, hypertension was identified as the independent variable for these symptoms. A limitation of the present study was that we recruited only patients with mild or no comorbidity. Conclusions: Excessive daily salt intake negatively affects pollakiuria and nocturia. The presence of hypertension can also represent a worsening factor for these symptoms. Although not shown by prospective study, the appropriate control of salt intake and blood pressure might be important for the treatment of pollakiuria and nocturia.
Introduction
LUTS are known to affect the QOL of patients. Nocturia among LUTS is associated with patient mortality. 1 In addition, among LUTS, pollakiuria and nocturia are reported to be the most bothersome symptoms. 2, 3 Reportedly, increased urinary frequency causes various pathophysiological conditions and lifestyle diseases, such as cardiovascular disease, diabetes mellitus, renal dysfunction, lower urinary obstruction and primary sleep disorders. [4] [5] [6] [7] Most previous reports suggest that hypertension strongly influences LUTS, including pollakiuria, and one of the chief causative factors of hypertension is excessive salt intake. [8] [9] [10] Furthermore, salt intake is known to be a direct and/or indirect cause of pollakiuria-related diseases, such as hypertension, cardiovascular disease and diabetic nephropathy. 11, 12 In addition to the aforementioned pathological conditions, physiological reactions to excessive salt intake can be the cause of pollakiuria. For example, increased water intake as a result of salt-induced high osmotic pressure of blood leads to pollakiuria, which is induced by polyuria. Therefore, salt intake is reported to be associated with increased urinary frequency. However, there are no reports in support of this hypothesis; several studies have reported that no significant relationship exists. 13, 14 We noticed that these reports had limitations and were prone to methodological bias, because salt intake was calculated using self-evaluation questionnaires on food intake. To our knowledge, there is little information available on the relationship between LUTS and salt intake evaluated objectively. As an objective method to evaluate daily salt intake, Tanaka's formula has been used in previous reports. 15 , 16 The reliability and usefulness of this method were confirmed in various pathological conditions including chronic kidney disease and hypertension. 17, 18 The main purpose of the present study was to clarify the relationships between objectively measured salt intake and LUTS, such as nocturia and CLSS. 19 In addition, we used multivariate models including salt intake, pollakiuria-related diseases and patient background to confirm the independent role of salt intake in LUTS.
Methods Patients
The present cross-sectional clinical study was carried out from April 2013 to March 2015 for patients with lower urinary tract symptoms in Nagasaki University Hospital, Nagasaki, Japan. Exclusion criteria were acute urinary tract infection, and any condition affecting urinary function, including a history of pelvic surgery, obvious bladder overactivity, benign prostatic hyperplasia, urethral stricture, pelvic organ prolapse, urological malignancy and neurogenic bladder. We enrolled 728 participants (229 men, 499 women) who visited our institution and were planned to be admitted for diseases other than those aforementioned into this study. Patients were divided into two groups based on the median salt intake (9.2 g/day): low salt intake group (L-salt group) and high salt intake group (H-salt group). This study was approved by the Nagasaki University Hospital Ethical Committee, and carried out in accordance with the principles of the Declaration of Helsinki. All participants provided written informed consent.
Evaluation of vital signs and urinary parameters
We defined hypertension as a systolic blood pressure of ≥140 mmHg and/or a diastolic blood pressure of ≥90 mmHg, or receiving therapy for hypertension. Body height (cm) and weight (kg) measures were recorded and used to calculate BMI using the standard formula (BMI = weight [kg]/height [m] 2 ). Diurnal urine volume was defined as total urine volume voided after the first morning void to the last void before bed. Nocturnal urine volume was defined based on the ICS standardization: total volume of urine passed during the night including the first morning void. NPi was defined as the ratio of nocturnal and 24-h total urine production. Sodium concentration in the spot urine test was represented as SUNa (Na concentration in the spot voiding urine). Renal dysfunction was defined as estimated glomerular filtration rate <60 mL/min/1.73 m 2 . In addition, patients with end-stage renal disease (estimated glomerular filtration rate <15 mL/ min/1.73 m 2 ) were excluded from the study.
Evaluation of LUTS and daily salt intake
We examined the relationship between LUTS (evaluated using the CLSS score) 20 and daily salt intake. In addition, we asked the participants to complete a 3-day frequency volume chart, and evaluated the average urinary volume and frequency of the 3-day data. We used the spot morning urine samples for estimated salt intake volume. We also asked the patients who were planned to be admitted to record a 3-day frequency volume chart, and collected their spot morning urine samples before their hospitalization. The daily salt intake was estimated by estimating the sodium and creatinine concentrations of spot urine samples using the formula mentioned below, which was adjusted for body height and weight, and age 18 
Statistical analysis
All data are expressed as mean AE SD, and values are described as mean AE SD. The Student's t-test was used to compare parametric continuous variables, and the v 2 -test was used for categorical comparisons. Pearson's correlation and the correlation coefficient (r) were used to evaluate the relationship between continuous variables, and the corresponding P-values are shown. Crude and adjusted effects were estimated by logistic regression analysis and described as OR with 95% CIs, along with P-values. All statistical tests were carried out on JMP 10 (SAS Institute, Cary, NC, USA).
Results
As summarized in Table 1 , the mean age was 62.6 AE 14.3 years, and mean BMI was 23.6 AE 4.4 kg/m 2 . The mean estimated daily salt intake was 9.3 AE 2.7 g (median 9.2 g, range 1.3-27.4 g). On comparing the L-salt group (n = 364) and H-salt group (n = 364), the mean age of the L-salt group (64.6 AE 15.0 years) was significantly (P < 0.001) higher compared with that of the H-salt group (60.7 AE 3.2 years). Conversely, the BMI of the L-salt group (21.7 AE 3.8 kg/m 2 ) was significantly (P < 0.001) lower compared with that of the H-salt group (23.0 AE 4.8 kg/m 2 ). Regarding medical conditions, 359 participants (49.3%) were found to have hypertension, and the prevalence of hypertension in the H-salt group (n = 228, 62.6%) was significantly (P < 0.001) higher compared with that in the L-salt group (n = 131, 36.0%). There was a significant difference in the prevalence of hyperlipidemia between the L-salt and H-salt groups (n = 74, 20.3% and n = 45, 12.4%, respectively; P < 0.001).
The data regarding urinary sodium concentration, excretion and intake are also summarized in Table 1 . When SUNa and estimated 24-h urinary sodium excretion were compared between the L-salt (81.5 AE 40.1 mEq/L and 125.6 AE 25.0 mEq/L, respectively) and H-salt groups (116.2 AE 52.0 mEq/L and 194.4 AE 33.9 mEq/L), both variables in the H-salt group were significantly higher (P < 0.001). In addition, a similar trend was found with regard to estimated daily salt intake (L-salt group: 7.3 AE 1.4 g/day and H-salt group: 11.4 AE 1.9 g/day; P < 0.001).
Regarding LUTS, daytime frequency in the H-salt group (8.4 AE 2.4) was significantly higher compared with that in the L-salt group (6.9 AE 2.5; P < 0.001). Similarly, a significant difference (P < 0.001) was also found in night-time frequencies between the H-salt (2.2 AE 1.3) and L-salt groups (1.4 AE 1.3). In addition to urinary frequency, the diurnal and nocturnal urine volumes of the H-salt group (1811.7 AE 477.7 mL and 517.7 AE 241.1 mL, respectively) were significantly higher (P < 0.001) than those of the L-salt group (1590 AE 502.3 mL and 153.7 AE 146.8 mL, respectively). Although voided volume in the L-salt group (249.8 AE 46.7 mL) was significantly higher than that in the H-salt group (232.8 AE 39.6 mL, P < 0.001), NPi in the Hsalt group (21.7 AE 7.9%) was significantly higher compared with that in the L-salt group (8.1 AE 7.4%; P < 0.001).
Similarly, on correlation analyses, estimated daily salt intake was positively correlated with daytime frequency (r = 0.36, P < 0.001; Fig. 1a ), night-time frequency (r = 0.38, P < 0.001; Fig. 1b) , diurnal urine volume (r = 0.27, P < 0.001; Fig. 1c) , nocturnal urinal volume (r = 0.50, P < 0.001; Fig. 1d ) and NPi (r = 0.35, P < 0.001; Fig. 1e) . Thus, two different statistical analyses showed that LUTS including urinary frequency and urine volume were influenced by salt intake.
Among the 10 items in CLSS, daytime frequency (Q1) and nocturia (Q2) scores significantly differed between the L-salt and H-salt groups (Table 2) . Briefly, the daytime frequency (Q1) score in the H-salt group (1.1 AE 0.9) was significantly higher compared with that in the L-salt group (0.6 AE 0.8; P < 0.001), and a similar trend was found for nocturia scores (Q2) (H-salt group = 1.8 AE 0.9 and L-salt group = 1.3 AE 1.0; P < 0.001). In contrast, the scores of other items did not differ significantly. On the other hand, the QOL score of the H-salt group (3.8 AE 1.6) tended to be significantly worse compared with that of the L-salt group (3.6 AE 1.6; P = 0.045). Based on these results, we carried out multivariate analyses to clarify the independent effect of salt intake on daytime frequency, nocturia and QOL index (Table 3) . Regarding daytime frequency (Q1), higher salt intake and hypertension were determined to be significant worsening factors, and both were also identified as independent factors on multivariate analysis. For nocturia (Q2), univariate analyses showed that daily salt intake, old age, male sex, high BMI, renal dysfunction and hypertension were significantly associated with a high frequency of night-time urination. Multivariate analysis showed that high salt intake was an independent factor influencing nocturia, as were sex, renal dysfunction and hypertension (Table 3 ). In contrast, QOL score was influenced by sex and hypertension, but not by salt intake (Table 3) .
Discussion
The present study shows that daily salt intake was associated with daytime urinary frequency, nocturia, and diurnal and nocturnal urine volume, and also that excessive daily salt intake was an independent risk factor for daytime pollakiuria and nocturia. Increased urinary frequency, especially nocturia, is well known to decrease QOL. 21 In addition, it is a risk factor for mortality.
1 Therefore, many investigators have investigated the causes of pollakiuria and nocturia. In particular, in adults, the relationships between urinary frequency and systematic disorders, lifestyle-related diseases, and eating habits are important to devise preventive and treatment strategies for these LUTS. In fact, as mentioned in the Introduction section, various types of diseases and chronic illness are known to cause increased urinary frequency. Interestingly, these pollakiuria-related pathological conditions are thought to have an association with excessive salt intake. [8] [9] [10] [11] [12] Therefore, we focused on daily salt intake in the present study.
Several investigators have previously reported on the relationships between salt intake and LUTS. 13, 14 However, in contrast to the present results, these studies showed no significant relationship between nocturia and salt intake. We cannot explain the reason of such a discrepancy by our study design. However, a possible reason is the relatively small sample size; for example, the study by Hendi et al. 13 included 60 patients, and that by Yoshimura et al.
14 included 72 patients. Another reason could be the ambiguity in analysis that might have influenced their results. In these previous reports, salt intake was estimated using a food intake record, 13 and LUTS were evaluated using a simple questionnaire.
14 For estimation of daily salt intake, two methods are mainly used: food intake record and urine samples. However, complete recording of food intake and accurate collection of urine are inconvenient and difficult for the patients. The evaluation method using spot urine samples is very easy compared with the 24-h urine collection samples, and the reliability of this method was confirmed by a systematic analysis. 22 Therefore, in recent years, many clinical researchers have used spot urine samples to estimate daily salt intake. 20, 22, 23 We hence used the spot urine sample method (Tanaka's formula) in the present study, and this method has already been validated in patients with hypertension or chronic kidney disease. 15, 24 Regarding the evaluation of nocturia, Yoshimura et al. used the "nocturia score" of the IPSS alone to determine the influence of salt intake on LUTS.
14 Therefore, this is the first study to investigate the relationship between salt intake and LUTS using a reliable objective method and an established symptom score system. In addition, we also investigated the influence of salt intake on urinary volume and NPi in the present study. Furthermore, some researchers suggested that there is the positive relationship between NUV, NPi and peripheral edema, [25] [26] [27] and excessive sodium intake might increase permeability, which can lead to peripheral edema in the interstitium at the capillary level. 13 For this reason, we believe that the NPi in the H-salt group was higher than in the L-salt group. Thus, the present results regarding pathogenic roles of salt intake on LUTS were obtained by objective and comprehensive analyses.
One of the most interesting results is the finding that daily salt intake was a significant and independent predictive factor for pollakiuria on multivariate analyses. Regarding daytime frequency, the present results might be caused by salt intakerelated polydipsia due to the increased osmotic pressure of blood. Generally, long-term high salt intake induces the activation of the renin-angiotensin system, especially in the kidney, and induces cell dehydration, which causes an osmotic imbalance. In addition, the activation of the renin-angiotensin system might also increase water intake. 28 In contrast, to our surprise, higher intake of daily salt was found to be a significant and independent aggravating factor for nocturia on multivariate analysis. That is, daytime eating habits can cause high voiding frequency at night-time. In the present study, the voided volume in the H-salt group was significantly lower than in the L-salt group. However, the difference of voided volume between the two groups was very small, and it might not be thought that it was clinically significant in a practical clinical setting. We hypothesize that endogenous hormones and increased circulating blood volume are causes of such phenomenon, although we did not analyze these parameters and their relationship in the present study. In short, increased water intake during daytime as a result of excessive salt intake leads to an increase in circulating blood volume, and subsequently ANP and BNP are stimulated as a consequence of volume overload. Finally, increased levels of ANP and BNP lead to nocturnal diuresis and nocturnal polyuria. 29 Urinary frequency is well known to be modulated by various factors including patient background, lifestyle, dietary habits and comorbidity. The present results obtained by univariate analyses supported these associations. In contrast, interestingly, we also found that salt intake-related nocturia was influenced by various other factors including age, sex, BMI, renal dysfunction and hypertension in contrast to high daytime urinary frequency, which is influenced only by hypertension. In addition, our multivariate analysis showed that high salt intake, male sex, renal dysfunction and hypertension were independently associated with nocturia. Briefly, nocturia is modulated by very complex mechanisms, and control of night-time urinary frequency is modulated by patient background, dietary habits and comorbidity.
The present results show that only hypertension is an independent risk factor for the worsening of all salt intake-related urinary disorders: high daytime voiding frequency, nocturia and decreasing of QOL score on the CLSS. The CLSS questionnaire addresses the following 10 symptoms: daytime frequency, nocturia, urgency, urgency incontinence, stress incontinence, slow stream, straining, incomplete emptying, bladder pain and urethral pain. 20 In addition, the CLSS has been confirmed for validity and reliability in men and women, and is a more simple and comprehensive assessment tool than the IPSS and Overactive Bladder Symptom Score, which are currently used, for patients with urinary symptoms. In addition, the CLSS includes the QOL score for urinary symptoms. Previous reports support the strong association between hypertension and pollakiuria including nocturia. 1, 8, 9 Therefore, appropriate management of blood pressure is suggested for management of pollakiuria. In addition, hypertension is also a well-known risk factor for various LUTS. However, in the present study, high daily salt intake, which is the main cause of hypertension and cardiovascular damage, did not affect the LUTS, except for daytime and night-time frequency on the CLSS. Although chronic excessive salt intake induces hypertension and cardiovascular damage, we do not know how long participants have had an excessive salt intake. The excessive salt intake state alone without vascular damage might not induce voiding and urgency symptoms. However, we showed that hypertension is associated with lower QOL in salt intakerelated pollakiuria for the first time. Based on these findings, we suggest that both limiting salt intake and managing blood pressure are essential to improve the QOL of patients with pollakiuria. There were some limitations of the present study. Briefly, we recruited not only healthy participants, but also patients with mild general complications, and we did not evaluate the sleeping hours, which affect the night-time frequency, hormonal assessment and amount of water intake. Furthermore, the CLSS is too simple to evaluate QOL impact. An additional limitation was the difference in clinical characteristics between our two groups. In general, chronic excessive salt intake leads to lifestyle-related diseases (e.g. hypertension, renal dysfunction and so on), and is influenced by age and sex. In these points, multivariate analyses were carried out to correct them. However, the sample size was sufficiently large, and we evaluated the correlation between salt intake and urological symptoms using established methods. Hence, the findings of the present study are significant. However, clinical studies including only healthy participants would be required to confirm the correlation between salt intake and urological symptom.
In conclusion, the present results suggest that high salt intake leads to pollakiuria, polyuria and worse QOL. Both daytime and night-time urinary frequency and volume are influenced by daily salt intake. Further detailed studies including sleeping hours, water intake, detailed evaluation of QOL impact and hormonal assessment are necessary to clarify the influence of daily salt intake in pollakiuria.
